Vascular Biology of Reactive Oxygen Species and NADPH Oxidases: Role in Atherogenesis by Adrian Manea
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
20 
Vascular Biology of Reactive Oxygen Species 
and NADPH Oxidases: Role in Atherogenesis 
Adrian Manea1,2 
1”Petru Poni”Institute of Macromolecular Chemistry, Iasi  
2“Nicolae Simionescu” Institute of Cellular Biology and Pathology, Bucharest 
Romania 
1. Introduction 
Eukaryotic cells face constantly the formation of reactive oxygen species (ROS) as a result of 
their aerobic metabolism. ROS play an important role in the regulation of signal 
transduction pathways and gene expression but its over-production is acutely harmful to 
cells, particularly in cardiovascular diseases (CVD) by a mechanism that is not fully 
understood. Most CVD (the leading cause of mortality in developed countries) entail the 
focal development of atherosclerotic plaques in response to various deleterious insults that 
affect the artery wall’s cells (Simionescu, 2007). Atheroma may occlude partially or totally 
the arterial lumen and ultimately, rupture of the vulnerable plaques results in thrombus 
formation and obstruction of the vessels of vital organs like heart, brain, lung, and kidney. 
Atheroma formation is characterized by progressive lipid accumulation in the vessel’s 
intima, dysfunctions of endothelial cells (EC) and smooth muscle cells (SMC), and a strong 
inflammatory reaction with the participation of extravasated immune cells (Fearon & Faux, 
2009). Compelling evidence (including ours) revealed that oxidative stress and NADPH 
oxidase - derived ROS play the key role in all stages of atherosclerosis and that genetic 
ablation of various oxidase components protects the cells against the detrimental effects of 
oxidative stress (Simionescu et al., 2009). Therefore, understanding the molecular 
mechanisms of ROS formation and function is a prerequisite of an effective anti-oxidative 
stress therapy.  
2. Reactive oxygen species formation in the vasculature 
As the name indicates, ROS are a class of highly reactive molecules derived from chemical 
conversion of molecular oxygen (O2). ROS are formed in all the aerobic cells and organisms 
as by-products of metabolic and respiration processes, under the influence of ionizing 
radiation or produced deliberately by specialized enzyme systems. ROS formation is 
initiated by reduction of O2 with one electron leading to the formation of short-lived and 
highly reactive superoxide anion (O2-). Successive reduction of O2-, protonation or 
interaction with various converting enzymes gives rise to a large spectrum of molecules 
with diverse physicochemical characteristics such as H2O2 and HO. The dismutation of 
O2- to H2O2 can be either spontaneous or catalyzed by specialized enzymes namely, 
members of the superoxide dismutase family. H2O2 may be completely reduced to H2O by 
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means of various peroxidases such as catalase and glutathione peroxidase or partially 
reduced to HO, one of the most powerful oxidizing agent identified in biological systems. 
The generation of HO is mediated by various free transition metal ions (e.g., Fe2+, Cu2+) via 
the Haber-Weiss reaction (Manea, 2010).  
Apart from the aforementioned chemical processing of O2, superoxide can react with other 
molecular species including nitrogen species such as nitric oxide (NO) or polyunsaturated 
fatty acids. The reaction between O2-   and NO is tightly controlled by the rate of diffusion 
of both radicals, and result in the formation of ONOO- a potent oxidant. Alternative 
reactions may led to the generation of mixed reactive oxygen and nitrogen radicals such as 
nitrogen dioxide radical (NO2) and nitryl chloride (NO2Cl) (Turrens, 2003).  
Lipid peroxidation products formation represents an important mechanism whereby ROS 
elicit physiological and pathophysiological function in the living cells. ROS (especially HO, 
NO2, and ONOO-) may react with polyunsaturated fatty acids present on biological 
membranes or circulating/infiltrated lipoproteins, a condition that facilitate the formation of 
fatty acid peroxyl radical (R-COO-) that can further attack adjacent fatty acid chains and 
trigger the production of other lipid radicals by a chain reaction mechanism (Negre-Salvayre 
et al., 2010; Riahi et al., 2010; Shao & Heinecke, 2009). 
Tyrosyl radicals produced by myeloperoxidase (MPO) have also been shown to be involved 
in the initiation of lipid peroxidation (Hazen et al., 1997). In vitro studies revealed that lipid 
peroxidation occurred only in the presence of free L-tyrosine suggesting that tyrosyl radicals 
formation by MPO are essential mediators for the initiation of lipid peroxidation and 
subsequent LDL oxidation by activated human neutrophils, which contain abundant MPO 
and H2O2 (Savenkova et al., 1994). Tyrosyl radicals have also been shown to play a role in 
LDL oxidation in vivo and in atherogenesis. Analysis of LDL isolated from human vascular 
tissue demonstrated that o,o’-dityrosine levels were 100 times greater than that observed in 
circulating LDL. Similarly, o,o’-dityrosine formation was found to be robust increased in 
atherosclerotic fatty streaks and in advanced atheromas compared to normal aortic tissue, 
indicating that tyrosyl radical formation was capable of protein damage in vivo 
(Leeuwenburgh et al., 1997). 
3. Molecular targets of ROS 
The biological function of ROS is highly regulated by their basic physicochemical properties, 
cellular compartmentalization and the formation rate. Since O2- is a short-lived charged 
species, it cannot diffuse through biological membranes and acts closeness of the formation 
site. Nevertheless, an anion channel-dependent plasma membrane transport mechanisms 
has been demonstrated to play an important role in mediating cell-to-cell communication. 
Notably, O2- is water-soluble and functions either as an oxidizing agent (e.g., one-electron 
reduction of O2- yields H2O2) or as a reducing agent (e.g., ONOO- formation). HO is 
extremely reactive and does not diffuse more that a few molecular diameters from its site of 
formation (Touyz, 2003). In contrast, H2O2 is highly stable under physiological conditions. 
Being an uncharged molecule, H2O2 is membrane-permeable and able of activating 
downstream signalling molecules relatively far from the site of formation. 
At low, physiological concentration, ROS modulate key signalling processes initiated by 
hormones, cytokines, vasoactive agents, blood coagulation factors, and hemodynamic shear 
stress. Reactive oxygen intermediates react at near-diffusion rate and influence the activity 
of numerous of signalling molecules including receptors, protein kinases/phosphatases, 
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transcription factors, peptides, ion channels and transporters, lipids, carbohydrates, and 
other oxygen-based species, a process that influence dramatically the cell behavior (Shao & 
Heinecke, 2009). The affinity of ROS for a specific substrate is dictated by both 
physicochemical features of the reactive oxygen intermediates and also of the targeted 
molecules. In addition, the occurrence and the abundance of specific functional groups, such 
as iron-sulfur centers, disulfide-bonds, amino and hydroxyl groups or fatty acids double-
bonds, greatly influence the chemical interactions between ROS and redox-sensitive 
biological molecules. As initially showed in microorganisms, eukaryotic cells respond to 
increased generation of O2- and H2O2 by the up-regulation of various gene products, 
largely antioxidant enzymes and molecules implicated in the preservation of cellular 
homeostasis, self-renewal, and reparatory processes. In terms of selectivity, O2- reacts 
preferentially with the transcription factors and electron transporters in respiratory chains 
containing iron-sulfur clusters. In contrast, H2O2 reacts mainly with the disulfide-bonds 
present on the protein kinases/phosphatases, transcription factors, and ion channels. 
Additional compelling evidence highlights that the redox-regulation of cell function 
represents an evolutionary conserved mechanism that alter directly or indirectly the 
activities of a large spectrum of signaling molecules (Liu et al., 2005).    
Protein tyrosine phosphatases (PTPs) are probably the best characterized signaling 
molecules targeted directly by ROS, especially of H2O2, owing to the existence of a highly 
conserved 230-amino-acid domain that contains reactive cysteine, which catalyzes the 
hydrolysis of protein phosphotyrosine residues. Consequently, a key mechanism whereby 
H2O2 controls various cellular processes is determined by the reversible oxidation of PTPs 
catalytic cysteines that blocks protein dephosphorylation causing transient inhibition of 
PTPs. 
Notably, several members of the protein tyrosine kinases (PTKs) family, including non-
receptor protein tyrosine kinases (i.e., Src, Jak, Pyk) have been shown to be activated in 
response to cellular redox variations (Tonks, 2006). Nevertheless, the precise molecular 
mechanisms of PTKs redox regulation are not entirely understood, and it is not clear if the 
PTK activities are directly correlated with the alterations induced by ROS action on enzyme 
structures Still, most of the available date suggests that the majority of the effects are 
attributable to PTP inhibition by ROS rather than PTK oxidation (Tabet et al., 2008). 
Another important class of molecules regulated by redox-dependent mechanisms is 
represented by the mitogen-activated protein kinase (MAPKs) family, that control key 
physiological processes such as mitosis, differentiation, proliferation, cell survival, and 
apoptosis. MAPKs are serine/threonine-specific protein kinases which activities are tightly 
regulated by complex phosphorylation pathways. Emerging evidence demonstrates that in 
the cardiovascular system, the functions of MAPKs are also influenced by extracellular and 
intracellular ROS by yet incompletely defined mechanisms (Wu et al., 2008). Apparently, the 
upstream regulators of MAPKs, namely MAPK kinases (MEKs), PTKs, and PTPs, might be 
the actual molecular targets of ROS and the genuine sensors of the intracellular redox state 
changes (Sedeek et al., 2009).  
Similar to PTPs, MAPK phosphatases (MKPs) display a highly conserved redox-sensitive 
cysteine in their catalytic core. Thus, the oxidative inhibition of MKPs may results in the 
persistent activation of MAPKs, as observed in various developmental or pathological 
states. Taken together, redox-dependent and as well as redox-independent activation of 
MAPKs cascades congregate to activate downstream signaling pathway in response to 
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hormones, growth factors, pro-inflammatory mediators, and vasoactive agents. Besides 
MAPKs, the activity of serine/threonine protein kinases Akt and Rho has been indicated to 
be redox-sensitive and to play a central role in cellular survival pathways (Lee & Griendling, 
2008). Apart from protein kinases/phosphatases and transcription factors, ROS are 
important regulators calcium homeostasis, by mechanisms that engages reversible thiol 
oxidation of the cysteine residues present on ion channels and transporters. In the vascular 
cells ROS, particularly O2- and H2O2, also enhance intracellular Ca2+ concentrations by 
increasing the extracellular influx through the plasma membrane channels and mobilization 
from intracellular stores, and by the inhibition of Ca2+-ATPases located in the plasma 
membrane and endoplasmic reticulum. The plasma membrane K+ channels have been 
shown to be redox-sensitive, a process that mediates hyperpolarization-dependent vascular 
relaxation (Belia et al., 2009; Briones &Touyz, 2010). These data indicates that the redox 
status of ion channels and transporters plays an essential role in cell physiology and 
represents an important determinant of vascular pathology under conditions of the altered 
production of ROS. 
4. Antioxidant mechanisms in the cardiovascular cells  
ROS are physiologically produced at low concentration during metabolic processes in non-
phagocytic cells, by the mitochondrial respiratory chain, cyclooxygenases, lipoxygesases, 
cytochrome P450 reductase, xanthine oxidase. 
Almost three decades ago, the commonly accepted assumption was that the antioxidant 
system has developed to defend the cells against the damaging and unavoidable effects of 
ROS, which are capable to  produce irreversible, structural, and functional oxidative damage 
of DNA, proteins, lipids, and carbohydrates. This theory was supported by many 
experimental evidence regarding the strategic tissular distribution, 
expression/concentration levels, and localization of the antioxidants within cellular 
compartments. Nevertheless, soon after the discovery of enzyme systems that deliberately 
generates ROS (e.g., NADPH oxidases) under physiological and pathological states, it has 
become apparent that ROS are not just the by-products of aerobic metabolism, but also 
important signalling molecules (Forman et al., 2010; Go & Jones 2010). Therefore, the subtle 
relationship among oxidizing and reducing agents permits ROS to function as second 
messengers and to regulate various cellular functions. Thus, besides neutralization of ROS, 
the antioxidant system has emerged as a critical regulator of the redox-sensitive processes. 
The concentration of various oxygen-based reactive intermediates is maintained in 
physiological range by a very complex antioxidant system comprising both enzymatic ROS 
scavengers, namely superoxide dismutase, catalase, glutathione peroxidase, thioredoxin, 
glutaredoxin, peroxiredoxin, heme oxygenase, and paraoxonase, and non-enzymatic ROS 
quenchers, such as glutathione, vitamins, lipoate, urate, and ubiquinone (Zadák et al., 2009). 
Superoxide dismutases (SOD) represent a family of enzymes that catalyze the dismutation 
of O2- into O2 and H2O2. Three SOD isoforms are expressed concomitantly in different 
cellular compartments, including the cytosol (SOD1; Cu/ZnSOD), mitochondria (SOD2; 
MnSOD), and the extracellular space (SOD3; ecSOD) (Valdivia et al., 2009). Catalase (CAT) 
is found in peroxisomes where it decomposes H2O2 to H2O and O2. Glutathione peroxidases 
(GPx) represent a family of isoenzymes encoded by separate genes that differ in cellular 
distribution pattern and substrate specificity. GPx1, the most abundant isoform, is expressed 
in the cytosol and has H2O2 as its main substrate. GPx2 is an extracellular space enzyme, 
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while GPx3 is particularly abundant in the plasma. GPx4 has as substrates lipid 
hydroperoxides and is present at a low level in nearly every cell type. Thioredoxins (TRx) 
and glutaredoxins (GRx) are proteins that function as antioxidants by enabling the reduction 
of other proteins by cysteine thioldisulfide exchange. Apart from being involved in 
antioxidant defense, different isoforms of the TRx and GRx families have been shown to 
play an important role in regulation of gene expression by redox-dependent processes. 
Peroxiredoxins (PRx) represent a ubiquitous family of antioxidant enzymes whose activities 
are tightly regulated by phosphorylation cascades and by changes in the redox and 
oligomerization states. PRx controls intracellular peroxide levels and mediate signal 
transduction in cardiovascular cells (Woo et al., 2010).  
5. Role of oxidative stress in atherogenesis 
Physiological production of ROS contribute to the preservation of vascular homeostasis by 
regulating important biological processes such as cell growth, proliferation, differentiation, 
apoptosis, cytoskeletal organization, and cell migration. Still, in the last few decades, it has 
become apparent that overproduction of ROS correlated with alterations of the antioxidant 
system, vascular inflammation and metabolic dysfunction are key pathological initiators of 
cardiovascular disorders. Generated in excess, ROS react randomly with all of biological 
molecules inducing the irreversible alterations of DNA, proteins, carbohydrates, and lipids 
components, thus altering cell functions (Martinet et al., 2001). As a result, extensive studies 
have concentrated on the role of oxidative stress-induced cellular dysfunction, redox control 
of vascular response to inflammatory and metabolic insults, the molecular mechanisms of 
ROS generation and the means that this class of molecules contributes to vascular damage. 
Oxidative stress represents a pathological condition characterized by the incapacity of 
antioxidant mechanisms to neutralize the deleterious effects of ROS and their metabolites. 
The means of oxidative stress onset and progression in vascular pathological states, include 
the overproduction of ROS, changes in the endogenous antioxidant system, and the 
production of various oxygen intermediates such as ONOO- and HO that cannot be 
efficiently buffered by the naturally occurring antioxidant mechanisms. In addition, spatial 
and temporal co-expression and co-localization of various enzymatic and non-enzymatic 
ROS-producing sources at the site of vascular insults may potentially exacerbate predispose 
to vascular insults and dysfunction (Kondo et al., 2009; Lee et al., 2009).  
The importance of oxidative stress in onset and development of atherosclerosis is 
commonly accepted (Fearon & Faux, 2009). Still, numerous clinical trials failed to 
demonstrate that the antioxidant therapy improve the health of patients with 
cardiovascular diseases (Yusuf et al., 2000). Consequently, many questions arise relative 
to our current knowledge of the molecular processes implicated in ROS formation and 
action. Hitherto, different pharmacological approaches have been employed to counteract 
oxidative stress-induced injury in the cardiovascular system i.e. antioxidant supplements 
containing vitamins C and E, polyphenols or selective inhibitors of distinct sources of ROS 
(Olukman et al., 2010). Nevertheless, these pharmacological interventions have many 
disadvantages such as inadequate concentration of active compounds at the site of ROS 
formation, or vitamins themselves becoming radicals with pro-oxidant activity or not 
being effective scavengers for various reactive oxygen/nitrogen intermediates, namely 
hydrogen peroxide (H2O2), peroxynitrite anion (ONOO-), hydroxyl anion (HO), and 
hypochlorous acid (HOCl).  
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Excessive ROS formation in atherogenesis triggers a chain of critical events such as EC 
dysfunction, oxidation of macromolecules especially LDL and extracellular matrix 
constituents, phenotypic alterations of SMC and macrophage/SMC-derived foam cell and 
modulate the function of signalling molecules in fibroblasts, which promotes inflammation 
of vascular adventitia (Sima et al., 2009). Vascular resident cells and transvasated immune 
cells are important sources of ROS within the atheroma (Heistad et al., 2009). These 
particularities show that atherosclerosis represents a multifactorial vascular disorder 
characterized by complex interactions and cross talk between the resident cells of the 
vascular wall, the cells of the immune system and the factors they produce. 
As shown in various animal models of atherosclerosis, oxidative stress is a primary 
occurrence and a key contributor to endothelial dysfunction portrayed by diminished 
endothelial NO bioavailability, enhanced endothelial transcytosis, up-regulation of pro-
inflammatory molecules, and the alteration of EC fibrinolytic activity (Dejana et al., 2009; 
Vendrov et al., 2007). In addition, oxidation of macromolecules especially of LDL (oxLDL) 
plays a key role in all stages of atherogenesis such as fatty streak formation, development of 
complex lesion, and plaque rupture. Of particular importance is that oxidative stress 
contributes, at least in part in the modulation of SMC phenotype switching and ultimately 
contributes to artery wall thickening. In atherosclerosis, SMCs undergo hypertrophy, 
produce excess extracellular matrix and inflammatory cytokines, proliferate and migrate 
from the media towards the vessel’s intima.  
Clinical evidence highlights that oxidative stress is a characteristic feature of many 
pathological conditions that predispose to atherosclerotic lesion formation such as 
hypercholesterolemia, hypertension, and diabetes. However, the precise pathological 
mechanisms accountable for the installation of oxidative stress are still an unsettled subject. 
In this context, although not completely validated in humans, oxidative stress may not be 
the sole causative effect of atherosclerosis and one has to consider the diversity of enzymatic 
and non-enzymatic sources of ROS, their vascular distribution pattern and subcellular 
compartmentalization, and complex regulation during various stages of the disease 
progression (Förstermann, 2008). 
6. Vascular sources of ROS: Role of NADPH oxidases 
Various pathways of ROS generation that can potentially contribute to oxidative stress have 
been described in the cardiovascular system including non-enzymatic decomposition of 
various compounds and metabolites (e.g., glucose autoxidation), production of ROS as 
byproducts of cellular respiration and metabolism (i.e., mitochondrial respiratory chain, 
lipo-/cyclooxygenases, dysfunctional nitric oxide (NO) synthases, cytochrome P450 
reductases, xanthine oxidase), lysosomal enzymes or generated in a highly regulated 
manner by specialized enzymes (e.g., NADPH oxidases) (Gu et al., 2001; Harrison et al., 
2003; Madamanchi et al., 2005; Martinez-Hervas et al., 2010; Zalba et al., 2007). 
NADPH oxidases (Nox) represent a family of multi-component enzymes, whose unique 
biological function is the production of ROS both in physiological and pathological states 
(Lambeth, 2004). Nox was originally identified and characterized as being a “burst” enzyme 
in professional phagocytes such as neutrophils and macrophages. In phagocytes, in 
cooperation with MPO, Nox plays a major role in host defense process against invading 
pathogens through the production of toxic hypochlorous acid (HOCl), a highly reactive 
oxidant. During phagocytosis, macrophages also generate significant amounts of NO. As a 
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result, the Nox-derived O2- reacts with NO thus producing ONOO-, an extremely cytotoxic 
chemical species which directly affect and oxidize biological molecules in invading 
microorganisms, resulting in molecular alteration and microbial death (El-Benna et al., 
2007). The phagocyte-type Nox consists of five subunits: a membrane-associated cytochrome 
b558, comprising a heavily glycosylated 91-kDa protein (gp91phox; Nox2) and non-
glycosylated 22-kDa subunit (p22phox), and three cytosolic regulatory components, 
p40phox, p47phox, and p67phox. Besides “Phox” components, assembly of Nox in an active 
complex requires the contribution of a low-molecular-weight GTP-binding protein, Rac1/2 
or Rap 1A. In latent cells, the Nox complex is dissociated but is rapidly assembled and 
activated following the exposure to pathogens or inflammatory mediators. Serine 
phosphorylation of p47phox represents the limiting step of Nox activation and triggers 
complex formation of cytosolic subunits followed by translocation to the membrane and 
association with cytochrome b558 (Hoyal et al., 2003; Lassègue & Griendling 2002; Li & Shah 
2003;). Other than Nox2, macrophages also express Nox1 and Nox4 as inducible isoforms 
that, reportedly mediate LDL oxidation in the vascular wall (Lee et al., 2009; Maitra et al., 
2009). 
The expression of functionally active Nox subtypes has been reported in non-phagocytes, 
including cardiovascular cells. Thus far, the members of the Nox enzyme family consists of 
seven isoforms (Nox1-5, Duox1/2), each with a particular cell and tissue distribution. Nox 
enzymes are broadly divided into three major categories, as a function of the extra catalytic 
domains to the phagocyte-type subunit Nox2. The first group includes Nox1, Nox3, and 
Nox4 isoforms, which display a number of similarities with Nox2, for instance their 
structural organization and molecular weight. Besides Nox2-type catalytic core, Nox5, the 
second group of the Nox family, possess an extra amino-terminal calmodulin-like domain 
that contains four Ca2+-binding EF-hands structures (Lambeth, 2007). Thus far, four splice 
variants of Nox5, namely Nox5┙, Nox5┚, Nox5┛, and Nox5├, have been identified in 
humans. In particular, the Nox5 gene is not present in the rodents’ genome. A third class of 
of Nox is represented by the Nox5-like dual oxidases (Duox) which possess, in addition to 
the Nox5-type structure, an extracellular peroxidase domain that uses the H2O2 generated 
by its Nox catalytic core. For their function, all the Nox1-4 subtypes necessitate the p22phox 
component, while Nox5 and Duox are activated directly by calcium. As shown in aortic 
SMCs, activation of Nox1 requires the participation of a ClC-3 anion transporter. The anion 
transporter co-expresses with Nox1 in early endosomes and is required for charge 
neutralization of the electron flow generated by Nox1 across the membrane of signalling 
vesicles (Miller et al., 2007). Nox4 is constitutively active and its activity is supported by the 
association with p22phox, required for the electron transfer, and polymerase delta 
interacting-protein 2 (Polidp2), that apparently may serve to stabilize the enzymatic 
complex (Lyle et al., 2009). The activities of Nox1, Nox2, and Nox3 isoforms are highly 
controlled by phosphorylation reactions involving regulatory subunits that initiate the 
assembly of Nox into an active enzymatic complex. Other than p40phox, p47phox, and 
p67phox cytosolic regulatory components, two different structurally related proteins have 
been discovered in non-phagocyte, specifically Nox organizer 1 (Noxo1), which is an analog 
of p47phox, and Nox activator 1 (Noxa1), which is an analog of p67phox. Despite the 
structural similarities, dissimilar functional aspects are involved in the regulation of enzyme 
activity. For instance, different to p47phox, which in the resting cells is located in the 
cytosol, Noxo1 is pre-localized at the membrane jointly with Nox1 and p22phox (Lambeth, 
www.intechopen.com
  
Atherogenesis 
 
432 
2004). Different subtypes of the Nox enzyme family along with their regulatory proteins are 
expressed in the cardiovascular cells (i.e., ECs, SMCs, vascular and cardiac fibroblasts, 
cardiac myocytes, and pericytes), and in circulating immune cells interacting with the blood 
vessels (i.e., monocytes/macrophages, neutrophils, lymphocytes, platelets, dendritic cells) 
(Manea et al., 2005).  
Nox subtypes are differentially located within the cellular compartments, suggesting a 
specific correlation between Nox subtypes, subcellular distribution and their specific 
function to control precise ROS-mediated signal transduction cascades. For instance, Nox1 
and Nox2 were detected in caveolae, in the plasma membrane, and endosomes. Nox4 has 
been detected in focal adhesions, mitochondria endoplasmic reticulum, and the nucleus 
(Ago et al., 2010; Kuroda & Sadoshima, 2010). Nox5 is present in the perinuclear regions, 
endoplasmic reticulum, and in the plasma membrane (BelAiba et al., 2007; Fulton, 2009). 
7. Involvement of Nox enzymes in atherogenresis  
Studies in cell culture and transgenic/knockout mice provided most of the existing data 
concerning the role of Nox-dependent oxidative stress in atherosclerosis. Nox activity is up-
regulated by numerous factors linked to atherosclerotic lesion formation and progression 
namely, inflammatory cytokines (tumor necrosis factor ┙, interferon ┛), vasoactive agents 
(angiotensin II, endothelin 1), metabolic factors (high glucose, modified 
proteins/lipoproteins/lipids, homocysteine), growth factors (platelet-derived growth 
factor), coagulation factors (thrombin), and pathological shear stress (Chung et al., 2010; 
Hwang et al., 2003). Apart from direct detrimental effects, compelling data exists that Nox-
derived ROS interact and stimulate other enzymatic sources of oxygen/nitrogen reactive 
intermediates, and generally amplify the initial response to insults (Cohena & Tong, 2010; 
Schrader & Fahimi, 2006).  
It is generally accepted that Nox-derived ROS cooperate, and act in concert with other 
pathological factors leading to vascular inflammation and injury, and that genetic ablation of 
various Nox subunits (i.e., p47phox, Nox1, Nox2) defends the vascular cells against the 
harmful effects of oxidative stress. ApoE-/- mice, which develop atherosclerotic lesions that 
cover the entire range of human lesions (i.e., fatty streaks, intermediate lesions, fibrous 
plaques, and vulnerable plaques exhibiting necrotic core and intra-plaque hemorrhage) have 
been extensively used to investigate the role of Nox enzymes in atherogenesis (Nakashima 
et al., 1994). Using this animal model, it has become evident that enhances in Nox activity 
and expression occur early in atherogenesis, and hyperactivity of Nox associated with the 
up-regulation of various isoforms marks all the stages of the plaque formation (Fenyo et al., 
2011).  
In contrast, ApoE/p47phox double-knockout mice display significantly less atherosclerotic 
lesions compared with ApoE-/- mice. In the same line, aortic O2- levels have been shown to 
be are lower in p47phox-/- mice than in wild-type mice. In addition, aortic SMCs from 
p47phox-/- mice exhibit a decreased proliferative response to growth factors compared with 
that of the SMCs of wild-type mice (Vendrov et al., 2007). 
Accelerated atherosclerosis represents a major vascular complication of diabetes mellitus 
and is responsible for 70-80% of deaths in diabetic patients in developed and developing 
countries. Numerous reports revealed that the Nox expression and activity are significantly 
up-regulated in the vasculature of diabetic subjects, and are associated with the 
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development of atherosclerosis and microvascular diseases (retinopathy, neuropathy, and 
nephropathy). In addition, Nox1, Nox2, and Nox4 are activated and up-regulated in the 
blood vessels of diabetic animals (Ding et al., 2007; Xu et al., 2007).  
Hyperglycemia, the primary clinical manifestation of diabetes, contributes at least in part to 
diabetic complications by inducing Nox and the ensuing oxidative stress. Moreover, 
advanced glycation end-products (AGEs), a direct consequence of the high and persistent 
blood glucose level, are also important inducers of Nox-derived ROS in vascular cells in 
diabetes. Besides hyperglycemia, hyperinsulinemia contribute to aberrant ROS production 
and vascular wall dysfunction. Since Nox is one of the main triggers of oxidative stress, it 
has a prominent role in the pathology of diabetes-induced vasculopathy (Gao & Mann, 
2009). These data make Nox enzymes potential therapeutic targets to counteract the 
deleterious effects of ROS in diabetes. 
Hypertension represents a major risk factor for atherosclerosis and its complications and 
several reports highlight that oxidative stress is both cause and consequence of hypertension 
(Briones & Touyz, 2010). Nox1 deficiency in mice reduces angiotensin II (Ang II) -dependent 
blood pressure, media hypertrophy, and extracellular matrix deposition, but not cell 
proliferation (Gavazzi et al., 2007; Matsuno et al., 2005). In agreement with these data, 
AngII-treated mice overexpressing Nox1 in vascular smooth muscle cells exhibit an increase 
of blood pressure, a condition that is associated with medial hypertrophy and significant 
production of ROS (Dikalova et al., 2005). Furthermore, overexpression of Nox1 in vascular 
SMCs leads to enhanced responsiveness to Ang II causing up-regulation of ROS, eNOS 
uncoupling and the consequent decline in NO bioavailability, followed by impaired 
vascular relaxation (Dikalova et al., 2010).  
Consistent with these reports, compared with wild-type mice, Nox2 ablation (Nox2-/-) 
diminishes robustly ROS-mediated protein oxidation, neointimal formation, SMCs 
proliferation and leukocyte accumulation, indicating that Nox2-mediated signalling and 
oxidation has a requisite role in the cell response to injury (Chen et al., 2004). 
The role of Nox4 and Nox5 enzymes in atherogenesis is less investigated and consequently, 
not entirely elucidated, since there are few atherosclerosis-related studies conducted on 
Nox4 deficient mice, and the Nox5 gene is not present in the rodent’s genome. Thus, most of 
the current data are provided by studies performed in vitro on various cell-types and 
isolated tissues.  
Recently, a Nox4 deficient mouse model and a cardiomyocyte-targeted Nox4-transgenic 
model have been developed to investigate the role of Nox4 during cardiac stress. (Zhang 
et al., 2010). One of the main breakthroughs of this study is that in contrast to the effects 
of generated by activated Nox1 or Nox2, the up-regulation cardiomyocyte Nox4 results 
in protection against pressure overload-induced adverse cardiac remodeling. The 
authors conclude that Nox4 facilitates the maintenance of myocardial capillary density 
during pressure overload by regulating stress-induced cardiomyocyte hypoxia inducible 
factor-1 activation and release of vascular endothelial growth factor, resulting in 
increased paracrine angiogenic activity. In addition, unlike Nox1, Nox2 or Nox5, it seems 
that Nox4 produces directly H2O2 and thus is incapable of scavenging NO or producing 
ONOO-. 
The beneficial effects of Nox4-derived ROS were also reported by means of a newly 
developed transgenic mouse with endothelial-specific Nox4 overexpression (Ray et al., 
2011). The authors showed that vascular segments and endothelial cells of these animals had 
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a significant increase in H2O2 generation rather that O2- and a significant augmentation of 
the pro-oxidative status. Despite of these aspects, the blood pressure of the animals was 
lower under basal conditions and after angiotensin II treatment. Interestingly, endothelium-
dependent relaxation was significantly improved compared with wild-type animals. 
Notably, these effects were sensitive to the ex vivo addition of catalase and in vivo 
administration of N-acetylcysteine, indicating that they were mediated by peroxide-type, 
namely H2O2, mechanisms. Mechanistically, it seems that an H2O2 action on potassium 
channels may be responsible for the elaboration of endothelium-derived hyperpolarizing 
factor (EDHF) type. Thus, one has to ponder that the type of ROS released in the vascular 
system determines their biological function. 
As mentioned above, less is know about the role of Nox5 in atherogenesis, and this is due 
mainly to the absence of Nox5 gene in the rodents’ genome and therefore to the lack of a 
reliable animal model., Still, it has been reported a significant correlation between Nox5 
expression and atherosclerotic lesion progression. Interestingly, a specific expression pattern 
was reported; with Nox5 being expressed mainly by the endothelium in the early stages of 
the disease while its expression is significantly increased in SMCs underlying fibro-lipid 
atherosclerotic lesions (Guzik et al., 2008).   
8. Mechanisms of Nox regulation 
8.1 Phosphorylation pathways and transcription factors 
Nox activity and expression is highly regulated at multiple levels by various physiologic 
and pathological factors which, by this means, dictate the enzyme complex function. The 
activities of both Nox1 and Nox2 isoforms are primarily regulated by complex 
networking of phosphorylation cascades involving regulatory components (i.e., p40phox, 
p47phox, p67phox, Noxo1, Noxa1) which induce the assembly of the enzyme complex. 
Nox4 is constitutively active and does not necessitate phosphorylation of regulatory 
proteins, whereas Nox5 has been demonstrated to be Ca2+-responsivenes. Yet, activation 
mechanisms involving protein kinase C and the proto-oncogenic tyrosine kinase c-Abl 
phosphorylation of Nox5 have been reported (El Jamali et al., 2008; Serrander et al., 
2007).   
The phosphorylation mechanisms responsible for Nox1 and Nox2 activation consist of a 
large spectrum of signalling molecules such as protein kinase C (PKC), phosphatidylinositol 
3-kinase (PI3K), GTP-binding proteins (Ras, Rac1/2), members of the mitogen-activated 
protein kinase (MAPK) family (p38MAPK, ERK1/2), phospholipases (PLC┚/┛, PLD), 
arachidonic acid metabolites, and non-receptor protein tyrosine kinases (Kilpatrick et al., 
2010; Yamamori et al., 2004). Besides the aforementioned kinases, chaperone proteins (e.g., 
protein disulfide isomerase) have been proved to be important regulators on Nox function 
(Janiszewski et al., 2005). 
In addition to the phosphorylation of cytosolic regulatory subunits, alterations of the Nox 
isoforms expression have been shown to be critical for their activity. Multiple transcription 
factors are coordinately implicated in the modulation of Nox expression and function. PU.1, 
Elf-1, IRF-1 (interferon regulatory factor-1), and ICSBP (interferon consensus sequence 
binding protein) are important transcriptional regulators of Nox2 in the myelomonocytic 
cell lineage (Kakar et al., 2005). In human colon epithelial Caco-2 cells, GATA-binding 
factors are critical for Nox1 transcriptional activity (Brewer et al., 2006), whereas in murine 
macrophages, the up-regulation of Nox1 in response to lipopolysaccharide (LPS) 
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stimulation is mediated at least in part, by pro-inflammatory transcription factors 
CCAAT/enhancer-binding protein (C/EBP)┚ and C/EBP├ (Maitra et al., 2009).  
In previous studies, we have shown that in human aortic SMCs exposed angiotensin II or 
tumor necrosis factor-┙, the pro-inflammatory transcription factor AP-1 is an essential 
regulator of the genes coding for p22phox, Nox1, and Nox4 components (Manea et al., 2008; 
Raicu & Manea, 2010). Other than, activator protein -1 (AP-1), the vascular inflammation-
related and growth-promoting transcription factors signal transducer and activator of 
transcription (STAT1 and STAT3) proteins physically interact with the promoters of human 
Nox1 and Nox4 genes in SMCs exposed to interferon (IFN) ┛ and a Jauns kinase 
(Jak)/STAT-dependent mechanisms are implicated in the ensuing O2- production. 
Moreover, the promoter activities of the genes coding for p22phox, p47phox, and p67phox, 
have been demonstrated to be considerably augmented in SMCs overexpressing 
STAT1/STAT3, a result that suggests the existence of functionally gamma activated 
sequence (GAS)/interferon-stimulated response element (ISRE) consensus sequences 
(Manea et al., 2010a). In human aortic SMCs, Ets1, a critical mediator of vascular 
inflammation and remodelling, regulates p47phox expression in response to AngII (Ni et al., 
2007). Similar observations were made in A7r5 cells and primary mouse aortic SMCs, in 
which the growth-promoting transcription factor E2F actually interacts and controls the 
Nox4 transcriptional program (Zhang et al., 2008).  
In atherosclerosis, and other major cardiovascular disorders, nuclear factor kB (NF-kB) 
signalling represents a critical regulating mechanism involved in disease onset and 
progression, including inflammation, cell proliferation, migration, differentiation and 
apoptosis. Several line of evidence indicate that NF-kB is a redox-sensitive transcription 
factor which is robustly activated by ROS possible generated by activated Nox. 
Interestingly, a positive feed-back loop of Nox activation by NF-kB has been proposed in 
several studies. Thus, a new integrative concept has emergedthe “vicious cycle”, to describe 
the interconnection between metabolic dysfunction, inflammation, and oxidative stress that 
converges to vascular disorders (Manea, 2010). In murine monocytes, the expression of the 
Nox2 is induced by NF-kB. Moreover, the up-regulation of p47phox and p22phox 
expression by LPS/IFN┛ was blunted in IkB┙-overexpressing cells suggesting the 
involvement of the NF-kB signaling in the regulation of the Nox components (Anrather et al. 
2006). Similar finding were reported in human monocytes/macrophages exposed to TNF┙ 
(Gauss et al., 2007). Moreover, in previous studies we have shown that, NF-kB is an 
important transcriptional regulator of the genes coding for p22phox, Nox1, and Nox4, and 
has a profound impact in the up-regulation of Nox activity in TNF┙-treated human aortic 
SMCs (Manea et al., 2007; Manea et al., 2010b). 
The molecular mechanisms that facilitate hypoxia sensing and related signalling events 
are critical for the maintenance of vascular cell homeostasis. Compelling data depicts that 
hypoxic conditions up-regulate the expression and activity various Nox subtypes (Goyal 
et al., 2004). It has been demonstrated that persistent hypoxia induces Nox4 gene and 
protein expression levels in pulmonary artery SMCs and in pulmonary vessels in mice 
exposed to hypoxic conditions (Diebold et al., 2010). Mechanistically, the response is 
dependent on hypoxia inducible factor-1┙ (HIF-1┙), which interacts with the 
corresponding elements in the Nox4 promoter. As a result, the HIF-1┙ dependent up-
regulation of Nox4 by may be an essential mechanism to preserve ROS level after hypoxia 
and the hypoxia-induced proliferation of pulmonary artery SMCs. Furthermore, 
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activating transcription factor-1 (ATF-1), a transcription factor of the CREB (CRE-binding 
protein)/ATF family, proved to play a key role in the induction of Nox1 in rat vascular 
SMCs (Katsuyama et al., 2005).  
Nuclear factor (erythroid-derived 2)-like 2, also known as Nrf2 represents a master 
modulator of the antioxidant responses by inducing genes (e.g., Sod genes) with important 
function in combating oxidative stress. Interestingly, it has been demonstrated that Nrf2, 
also controls Nox4 expression in mouse lung and human lung endothelium in response to 
hyperoxia (Pendyala & Natarajan, 2010). 
8.2 Genetic and epigenetic mechanisms of Nox regulation 
Genetic studies highlight that several Nox-related polymorphisms are closely associated 
with an increased susceptibility for cardiovascular disorders. One of the most investigated 
genes from the Nox complex is CYBA which encodes the p22phox essential subunit. The 
p22phox is ubiquitously expressed in cardiovascular cells and forms stable and functional 
heterodimers with Nox1, Nox2 or Nox4, a critical structure for enzyme activity as shown 
by studies employing siRNA technology to knock-down p22phox expression (Kawahara 
et al., 2005). Moreover, it has been demonstrated that p22phox is more abundant in 
advanced atherosclerotic plaques than in nonatherosclerotic arteries, suggesting a 
correlation between p22phox expression, O2- production, and the severity of 
atherosclerosis (Azumi et al., 1999).  
The occurrence of particular polymorphisms of the CYBA gene has been shown to 
predispose to oxidative stress and to be independently correlated with cardiovascular risk 
factors and disease occurrence namely hypertension, coronary artery disease, myocardial 
infarction, cerebrovascular disease, diabetic and non-diabetic nephropathy) (San José et al., 
2008). Various CYBA allelic variants were detected in both exonic sequences such as C242T, 
A640G, C549T (Dinauer et al., 1990; Guzik et al., 2000; Inoue et al., 1998), and promoter 
regions namely -930A/G, -675A/T, -852C/G, -536C/T (Lim et al., 2006; Moreno et al., 2007), 
which potentially affect the p22phox expression and consequently the Nox activity. Thus 
far, data indicating the existence of functional Nox1-5 polymorphisms with a relevant 
impact on vascular pathology are not available yet.     
Emerging evidence demonstrates that epigenetic events such as DNA methylation and 
modifications of histone tails are important processes of oxidative stress onset. DNA 
methylation mechanisms of the promoter CpG islands has been shown to be involved in the 
up-regulation of 15-lipoxygenase, a pro-oxidative enzyme with implications in plaque 
formation and vulnerability, and down-regulation of superoxide dismutase 3, endothelial 
NO synthase, and various anti-proliferative genes (estrogen receptor-┙), a condition that 
leads to oxidative stress, impaired vascular relaxation, and aberrant SMC hyperplasia 
(Fernandez et al., 2010). Hitherto, data about the role of epigenetics in the regulation of Nox 
subtypes are missing. Nevertheless, using both in vitro (e,g., human aortic SMCs exposed to 
pro-inflammatory conditions) and in vivo (ApoE-/- mice fed a high fat, cholesterol rich diet) 
models, we have found recently that an aberrant methylation of the Nox1 promoter may be 
responsible for the up-regulated expression and activity of this enzyme (Manea et al., 
unpublished data).  
A schematic representation of the key molecular pathways implicated in the up-regulation 
of Nox enzymes as well as the potential pharmacological targets intended to counteract 
oxidative stress are presented in the figure below.   
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Fig. 1.  Schematic depiction of the major mechanisms responsible for the up-regulation of 
Nox enzymes and installation of oxidative stress in atherosclerosis. In response to 
cardiovascular risk factors, vascular cells through their receptors activate a range of 
signalling pathways that up-regulate Nox expression, activity, and the ensuing ROS 
production. This triggers a chain of critical events that generally amplify the initial response 
to vascular insults (i.e., activation of other cellular sources of ROS and redox-sensitive 
signalling effectors). Persistent Nox activation leads to oxidative stress that is a major 
contributor to the initiation and the development of atherosclerotic lesions. The diagram 
highlights that genetic, epigenetic, as well as genetic/non-epigenetic-independent 
mechanisms linked to Nox up-regulation and hyperactivity in atherosclerosis may be used 
to target and control pharmacologically the Nox-derived oxidative stress (green text).  
9. Conclusion 
The Nox-derived ROS may have both beneficial and deleterious effects. Thus, we can safely 
assume that these effects are function of the expression pattern and regulation of various 
Nox isoforms, their subcellular compartmentalization, and the rate of ROS generation. 
Despite of the numerous existing data, the precise mechanisms of Nox regulation in 
atherosclerosis and the stream of signalling molecules (up-, or down-regulated) responsible 
for the increased oxidative stress that is associated with the onset and development of 
cardiovascular dysfunction, is poorly understood. Thus, a complex interplay of genetic, 
epigenetic and non-epigenetic factors, transcription factors, co-activators, and/or co-
repressors may be coordinately involved in the up-regulation of Nox activity in 
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atherogenesis. Therefore, elucidation of the complex interactions among different 
mechanisms that control Nox subtypes expression/activity and subcellular 
compartmentalization of ROS production and its subsequent biological meaning, may lead 
to a more focused and effective antioxidant therapies. The expected impact of these 
pharmacological strategies goes well beyond the atherosclerosis field. Oxidative stress is a 
common occurrence in most pathologies i.e. diabetes, neurodegenerative diseases, cancer, 
etc. The knowledge gained will be applicable to all these pathologies since controlling 
oxidative stress ought to have a beneficial knock-on effect on these diseases. Identifying the 
basic molecular mechanism regulating the oxidative stress will be used to find ways to 
manage its occurrence and correct its adverse effects. 
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